Alcohol Clinical Trials in New York, New York
22 recruitingNew York, New York
Showing 1–20 of 22 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
89bio, Inc.762 enrolled296 locationsNCT06419374
Recruiting
Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc.1,350 enrolled342 locationsNCT06318169
Recruiting
Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
MASH - Metabolic Dysfunction-Associated SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc2,150 enrolled318 locationsNCT06528314
Recruiting
Phase 3
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Non-Alcoholic Fatty Liver Disease
GlaxoSmithKline1,200 enrolled49 locationsNCT07221227
Recruiting
Phase 3
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-Alcoholic Fatty Liver Disease
GlaxoSmithKline1,250 enrolled43 locationsNCT07221188
Recruiting
Phase 1
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Insulin ResistanceNon-Alcoholic Fatty Liver DiseaseOverweight and Obesity+1 more
Columbia University32 enrolled1 locationNCT06354088
Recruiting
Phase 2
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
Liver Diseases, Alcoholic
GlaxoSmithKline393 enrolled131 locationsNCT06613698
Recruiting
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
Nonalcoholic SteatohepatitisNonalcoholic Fatty Liver
Target PharmaSolutions, Inc.15,000 enrolled74 locationsNCT02815891
Recruiting
Phase 2
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)
Alcohol Liver Disease
Altimmune, Inc.100 enrolled43 locationsNCT07009860
Recruiting
Not Applicable
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
Non-Alcoholic Fatty Liver Disease
Weill Medical College of Cornell University40 enrolled1 locationNCT05332613
Recruiting
Not Applicable
A Female-Specific CBT Group for Veteran Women With Alcohol Use Disorder in VA Primary Care Settings
Alcohol Use DisorderRisky Health Behavior
University of Massachusetts, Worcester162 enrolled1 locationNCT06118346
Recruiting
Early Phase 1
Anxiety During Abstinence in AUD
Alcohol Use Disorder
Columbia University60 enrolled1 locationNCT06793488
Recruiting
Phase 2
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
CirrhosisCirrhosis, LiverCirrhosis Due to Hepatitis B+5 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)256 enrolled13 locationsNCT05832229
Recruiting
Phase 2
Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD
Alcohol Use Disorder
NYU Langone Health200 enrolled2 locationsNCT06349083
Recruiting
Not Applicable
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
NASH - Nonalcoholic Steatohepatitis
Perspectum225 enrolled7 locationsNCT04054310
Recruiting
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
SmokingSmoking, TobaccoSmoking, Cigarette+5 more
Memorial Sloan Kettering Cancer Center5,122 enrolled1 locationNCT06535867
Recruiting
Not Applicable
Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study
Alcohol Drinking
Icahn School of Medicine at Mount Sinai280 enrolled1 locationNCT05675332
Recruiting
Phase 2
FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study
Alcohol Associated Hepatitis
Intercept Pharmaceuticals80 enrolled31 locationsNCT05639543
Recruiting
Phase 2
Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD
Post Traumatic Stress DisorderAlcohol Use Disorder
NYU Langone Health150 enrolled1 locationNCT03667846
Recruiting
Evaluating Alcohol Use in Alcoholic Liver Disease
Alcoholic Liver Disease
Nicole T Shen160 enrolled1 locationNCT03267069